MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

Bullboard Posts

Post by Notmyname1on Sep 04, 2020 10:48am

275 Views

Post# 31510125

Medmira was 100% thinking about this message….

to give out at this point. And I assume that
in the next week something will happen. If all of this is correct-
and I assume - it is completely incomprehensible to the FDA
(which has had this for months) apparently not able to
has to be completed. And that in times when the USA is currently facing the pandemic
does one of the worst in the world.

Bullboard Posts

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity